These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9825395)
1. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395 [TBL] [Abstract][Full Text] [Related]
2. Intravesical vanilloids and neurogenic incontinence: ten years experience. Lazzeri M; Spinelli M; Zanollo A; Turini D Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356 [TBL] [Abstract][Full Text] [Related]
3. Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. Kim JH; Rivas DA; Shenot PJ; Green B; Kennelly M; Erickson JR; O'Leary M; Yoshimura N; Chancellor MB J Spinal Cord Med; 2003; 26(4):358-63. PubMed ID: 14992337 [TBL] [Abstract][Full Text] [Related]
4. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study. de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887 [TBL] [Abstract][Full Text] [Related]
5. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders. Cruz F Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(4):214-20. PubMed ID: 9795827 [TBL] [Abstract][Full Text] [Related]
6. Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. Lazzeri M; Beneforti P; Turini D J Urol; 1997 Dec; 158(6):2093-6. PubMed ID: 9366319 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions. Kuo HC BJU Int; 2003 Oct; 92(6):597-601. PubMed ID: 14511042 [TBL] [Abstract][Full Text] [Related]
8. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity. Watanabe T; Yokoyama T; Sasaki K; Nozaki K; Ozawa H; Kumon H Int J Urol; 2004 Apr; 11(4):200-5. PubMed ID: 15028097 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. Kuo HC J Urol; 2003 Sep; 170(3):835-9. PubMed ID: 12913711 [TBL] [Abstract][Full Text] [Related]
11. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Silva C; Rio ME; Cruz F Eur Urol; 2000 Oct; 38(4):444-52. PubMed ID: 11025384 [TBL] [Abstract][Full Text] [Related]
12. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393 [TBL] [Abstract][Full Text] [Related]
13. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study. Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783 [TBL] [Abstract][Full Text] [Related]
15. Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. de Sèze M; Wiart L; Joseph PA; Dosque JP; Mazaux JM; Barat M Neurourol Urodyn; 1998; 17(5):513-23. PubMed ID: 9776014 [TBL] [Abstract][Full Text] [Related]
16. Urodynamic assessment during intravesical infusion of capsaicin for the treatment of refractory detrusor hyperreflexia. Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D Spinal Cord; 1999 Jun; 37(6):440-3. PubMed ID: 10432264 [TBL] [Abstract][Full Text] [Related]
17. New therapeutic options for refractory neurogenic detrusor overactivity. Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033 [TBL] [Abstract][Full Text] [Related]
18. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Apostolidis A; Gonzales GE; Fowler CJ Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519 [TBL] [Abstract][Full Text] [Related]
19. Role of C afferent fibers and monitoring of intravesical resiniferatoxin therapy for patients with idiopathic detrusor overactivity. Yokoyama T; Nozaki K; Fujita O; Nose H; Inoue M; Kumon H J Urol; 2004 Aug; 172(2):596-600. PubMed ID: 15247740 [TBL] [Abstract][Full Text] [Related]
20. Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity. Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C Neurourol Urodyn; 2019 Aug; 38(6):1540-1550. PubMed ID: 31180583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]